Zuhir PBL-IV (Diabetes)
-
Upload
darkwarriormfh22 -
Category
Documents
-
view
223 -
download
0
Transcript of Zuhir PBL-IV (Diabetes)
-
7/31/2019 Zuhir PBL-IV (Diabetes)
1/36
PBL-IVZuhir Bodalal
Libyan International Medical University
www.limu.edu.ly
http://www.limu.edu.ly/http://www.limu.edu.ly/ -
7/31/2019 Zuhir PBL-IV (Diabetes)
2/36
Disclaimer
The following is a collection of medical
information from multiple sources, both
online and offline. It is to be used for educational purposesonly.
All materials belong to their respective owners
and the authors claims no rights over them.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
3/36
Classifications of MG
-
7/31/2019 Zuhir PBL-IV (Diabetes)
4/36
Classifications
Modified Osserman and Genkin classification.
Oosterhuisclassification. Result classification.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
5/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
6/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
7/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
8/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
9/36
Pathophysiology
-
7/31/2019 Zuhir PBL-IV (Diabetes)
10/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
11/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
12/36
Pathophysiology
Anti-AChRantibody is found in 80-90% of patients with MG
Proven with passive transfer experiments
Increase turnover of AChR
Blockade at AchR Damage postsynaptic ms. membrane
MG may be considered a B cell-mediated disease
Antibodies
-
7/31/2019 Zuhir PBL-IV (Diabetes)
13/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
14/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
15/36
Etiology
-
7/31/2019 Zuhir PBL-IV (Diabetes)
16/36
Causes
Idiopathic
Penicillamine Drugs
-
7/31/2019 Zuhir PBL-IV (Diabetes)
17/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
18/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
19/36
D-penicillamine
Alpha interferons
Bone marrow transplantation
Botox
-
7/31/2019 Zuhir PBL-IV (Diabetes)
20/36
Investigations
-
7/31/2019 Zuhir PBL-IV (Diabetes)
21/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
22/36
Work-up
Lab studies
Interleukin-2 receptors
Increased in generalized and bulbar forms of MG
Increase seems to correlate to progression of disease
-
7/31/2019 Zuhir PBL-IV (Diabetes)
23/36
Work-up
Imaging studies
Chest x-ray
Plain anteroposterior and lateral views may identify athymoma as an anterior mediastinal mass
Chest CT scan is mandatory to identify thymoma
MRI of the brain and orbits may help to rule outother causes of cranial nerve deficits but shouldnot be used routinely
-
7/31/2019 Zuhir PBL-IV (Diabetes)
24/36
Electrodiagnostic studies:Repetitive Nerve Stimulation
Low frequency RNS (1-5Hz)
Locally available Ach becomes depleted at all NMJsand less available for immediate release
Results in smaller EPSPs
-
7/31/2019 Zuhir PBL-IV (Diabetes)
25/36
Thymectomy
-
7/31/2019 Zuhir PBL-IV (Diabetes)
26/36
Present indications for thymectomy Patient with thymoma the thymectomy is
indicated all.
If no thymoma the patient age, symptoms,
duration, severity, response to medication,sex are factors in decision-making.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
27/36
Present indications for thymectomy Thymectomy is not recommended for the
neonatal type of myasthenia gravis.
In juvenile form the reserve thymectomyfor patient with more severe symptoms and
lack of response to medical therapy.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
28/36
Present indications for thymectomy
In adult Cooper, Jaretzki and Papatestasallbelieved patient with general symptoms shouldreceive early thymectomy as soon as the
diagnosis established. The ocular type may try medical therapy for a
year and if the symptoms interfere the daily life,the thymectomy should be considered.
High incidence of unsuspected thymoma inpatient older than 40y/o with ocular symptomonly.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
29/36
Result
Adult patient without thymoma undergoing
thymectomy has higher incidence of complete
remission.
Complete remove all thymic tissue fom
mediastium and lower neck from standardtransternal incision is required in surgical
treatment of myasthenia gravis.
-
7/31/2019 Zuhir PBL-IV (Diabetes)
30/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
31/36
Management
-
7/31/2019 Zuhir PBL-IV (Diabetes)
32/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
33/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
34/36
Differentials
Amyotropic LateralSclerosis
Basilar Artery Thrombosis
Brainstem gliomas Dermatomyositis
Lambert-EatonMyasthenic Syndrome
Multiple Sclerosis
SarcoidosisandNeuropathy
Thyroid disease Botulism
Oculopharyngealmuscular dystrophy
-
7/31/2019 Zuhir PBL-IV (Diabetes)
35/36
-
7/31/2019 Zuhir PBL-IV (Diabetes)
36/36
Thank You